New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) being held online identifies drugs that could potentially be repurposed for the treatment of gonorrhea (Neisseria gonorrhoeae): a sexually transmitted infection which is becoming increasingly resistant to existing antibiotics.